Expansion Chemicals & Petrochemicals NSE: TATVA ·

Tatva Chintan Pharma Chem Commences New Greenfield Unit at Dahej-III in Gujarat

NSE Filing 4 min read 14 views
Tatva Chintan Pharma Chem Commences New Greenfield Unit at Dahej-III in Gujarat

Tatva Chintan Pharma Chem Limited — Expansion · TATVA

Market Cap

₹4,008.7 Cr

Mid-cap

Day Price Change

20%

Daily gain

Revenue TTM

₹556.05 Cr

Trailing 12 months

Promoter Holding

72.02%

Stable ownership

! Key Highlights

  • Groundbreaking ceremony (Bhoomi Pujan) successfully held on July 20, 2026
  • New manufacturing facility located at Dahej-III, Dahej Industrial Estate, Gujarat
  • Strategic site choice in Bharuch district offers high logistical and industrial connectivity
  • Expansion aimed at strengthening internal infrastructure and production capabilities
  • Project aligns with the company's long-term growth and market demand fulfillment strategy

Tatva Chintan Pharma Chem Limited has initiated the construction of a new greenfield manufacturing unit at Dahej-III in Gujarat. The groundbreaking ceremony marks a significant step in the company's strategy to scale its production capacity to meet rising global demand for specialty chemicals.

Expansion at Dahej Industrial Estate

Tatva Chintan Pharma Chem Limited has officially commenced the construction of its new greenfield manufacturing facility at the Dahej Industrial Estate in Gujarat. The groundbreaking ceremony, also known as Bhoomi Pujan, took place on July 20, 2026, at the Dahej-III site located in the Vagra taluka of Bharuch district. This project follows an initial intimation provided by the company on July 17, 2026.

The new unit is designed to scale up the company's existing production footprint and is strategically positioned within one of India's most prominent industrial hubs for chemical manufacturing, ensuring access to critical infrastructure and raw material supply chains.

Strategic Rationale for Greenfield Unit

  • Capacity addition is a core component of the company's long-term growth strategy to enhance internal infrastructure
  • The site at Dahej-III provides significant logistical advantages due to its proximity to major chemical clusters and port facilities
  • New facility is specifically aimed at addressing the increasing global and domestic market demands for complex specialty chemicals
  • Establishing a greenfield unit allows for the implementation of modern, high-efficiency manufacturing technologies from the ground up
  • Expanded production footprint is expected to bolster the company's competitive standing in the high-growth chemical sector

Business Model and Market Presence

Tatva Chintan operates as a specialized chemical manufacturer focusing on Structure Directing Agents, Phase Transfer Catalysts, and electrolyte salts for supercapacitor batteries. The company serves a diverse global clientele across the automotive, petroleum, pharmaceutical, and agrochemical industries. Revenue is primarily generated through the production of complex chemistries that require high levels of technical expertise and precision.

This new expansion at Dahej-III will likely support the scaling of these high-value product lines, allowing the firm to capture a larger share of the specialty chemicals market while optimizing its operational efficiency through consolidated manufacturing in the Gujarat region.

Financial Performance and Context

The expansion comes during a period of robust financial performance, with the company reporting an annual revenue growth of 32.3% and a significant net profit surge of over 636% in the last fiscal year. With a market capitalization of approximately ₹4,008.7 crore and a high promoter holding of 72.02%, the company maintains a stable equity structure. Recent quarterly data shows a 42.95% year-on-year increase in revenue, reaching ₹167.06 crore.

The stock has demonstrated strong momentum, recently hitting a 1-year high of ₹1,713.7, reflecting positive market sentiment regarding its aggressive capacity expansion plans and operational scaling.

Tatva Chintan Pharma Chem Limited — Financial Snapshot

BSE: 543321 · NSE: TATVA · Chemicals & Petrochemicals

Current Market Price ₹1713.7 per share
Market Capitalisation ₹4,008.70 Cr BSE Listed
Revenue (Annual) ₹505.86 Operating
Net Profit (Annual) ₹42.05 Consolidated
P/E Ratio (TTM) 78.01× Sector: 44.63×
Promoter Holding 72.02% 0.00% QoQ
FII Holding 3.93% Current Qtr

Source Verified

Exchange filing by Tatva Chintan Pharma Chem Limited announcing the groundbreaking ceremony of its new greenfield manufacturing unit. Financial metrics from Trendlyne.

View Filing